Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



The efficacy of fractional CO2 laser resurfacing in the treatment of facial acne scars

Abdul Hakeem Mohammad Saeed, Salaiman Ayed Alsaiari.




Abstract

Background: Acne is a common condition with prevalence as high as 80% among adolescents and often it causes atrophic scars. Laser resurfacing is an effective treatment for acne scars. However, post-treatment adverse effects are often induced. Fractional laser photothermolysis has been designed to create microscopic thermal wounds to achieve skin rejuvenation without significant side effects.

Objectives: The aim of this study is to assess the efficacy and safety level of fractional CO2 laser in atrophic acne scars treatment.

Materials and Methods: Forty patients between 18 and 40 years of both sexes with atrophic acne scars seen in the Department of Dermatology at Najran University Hospital in Najran, Saudi Arabia, were treated with 4–6 sessions of fractional CO2 laser resurfacing. The result was evaluated objectively at each follow-up visit and 3 months after the last laser session using a quartile grading scale. Patient improvements were classified as excellent when the improvement was >50% in scar outcome and appearance of skin, good if 25–50% response, and poor when the response

Key words: Acne Scars; Pitting Scar; Rolling Scars; Fractional CO2 Laser Resurfacing






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.